Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.50
UNH's Cash to Debt is ranked higher than
71% of the 31 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.50 vs. UNH: 0.50 )
UNH' s 10-Year Cash to Debt Range
Min: 0.46   Max: No Debt
Current: 0.5

Equity to Asset 0.39
UNH's Equity to Asset is ranked higher than
85% of the 34 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.37 vs. UNH: 0.39 )
UNH' s 10-Year Equity to Asset Range
Min: 0.3   Max: 0.81
Current: 0.39

0.3
0.81
Interest Coverage 13.59
UNH's Interest Coverage is ranked higher than
83% of the 29 Companies
in the Global Health Care Plans industry.

( Industry Median: 8.28 vs. UNH: 13.59 )
UNH' s 10-Year Interest Coverage Range
Min: 8.24   Max: 9999.99
Current: 13.59

8.24
9999.99
F-Score: 5
Z-Score: 3.19
M-Score: -2.21
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 7.69
UNH's Operating margin (%) is ranked higher than
91% of the 34 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.21 vs. UNH: 7.69 )
UNH' s 10-Year Operating margin (%) Range
Min: -0.24   Max: 10.94
Current: 7.69

-0.24
10.94
Net-margin (%) 4.37
UNH's Net-margin (%) is ranked higher than
91% of the 34 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.08 vs. UNH: 4.37 )
UNH' s 10-Year Net-margin (%) Range
Min: -0.96   Max: 6.64
Current: 4.37

-0.96
6.64
ROE (%) 16.71
UNH's ROE (%) is ranked higher than
91% of the 34 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.20 vs. UNH: 16.71 )
UNH' s 10-Year ROE (%) Range
Min: -4.11   Max: 31.61
Current: 16.71

-4.11
31.61
ROA (%) 6.44
UNH's ROA (%) is ranked higher than
94% of the 34 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.60 vs. UNH: 6.44 )
UNH' s 10-Year ROA (%) Range
Min: -1.72   Max: 9.55
Current: 6.44

-1.72
9.55
ROC (Joel Greenblatt) (%) 227.07
UNH's ROC (Joel Greenblatt) (%) is ranked higher than
94% of the 33 Companies
in the Global Health Care Plans industry.

( Industry Median: 131.62 vs. UNH: 227.07 )
UNH' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -14.29   Max: 655.11
Current: 227.07

-14.29
655.11
Revenue Growth (%) 12.90
UNH's Revenue Growth (%) is ranked higher than
70% of the 30 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.70 vs. UNH: 12.90 )
UNH' s 10-Year Revenue Growth (%) Range
Min: 9.7   Max: 41.8
Current: 12.9

9.7
41.8
EBITDA Growth (%) 10.90
UNH's EBITDA Growth (%) is ranked higher than
88% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 8.60 vs. UNH: 10.90 )
UNH' s 10-Year EBITDA Growth (%) Range
Min: -38.7   Max: 149.6
Current: 10.9

-38.7
149.6
EPS Growth (%) 10.30
UNH's EPS Growth (%) is ranked higher than
85% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 7.70 vs. UNH: 10.30 )
UNH' s 10-Year EPS Growth (%) Range
Min: 1.3   Max: 37.8
Current: 10.3

1.3
37.8
» UNH's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

UNH Guru Trades in Q3 2013

NWQ Managers 3,154 sh (New)
Dodge & Cox 6,200,700 sh (+474.26%)
Sarah Ketterer 941,734 sh (+27.6%)
Jeremy Grantham 6,609,403 sh (+17.49%)
Pioneer Investments 229,965 sh (+10.25%)
Steven Cohen 18,575 sh (+4.03%)
Jeff Auxier 130,405 sh (+2.76%)
Tom Gayner 576,300 sh (+1.14%)
Chris Davis 14,880,244 sh (+0.88%)
Bill Nygren 3,460,000 sh (unchged)
Leon Cooperman 1,224,933 sh (unchged)
John Burbank 1,000,000 sh (unchged)
Bernard Horn 41,284 sh (unchged)
Ken Heebner Sold Out
John Buckingham Sold Out
Louis Moore Bacon Sold Out
HOTCHKIS & WILEY 5,737,924 sh (-0.94%)
Mario Gabelli 383,191 sh (-1.69%)
RS Investment Management 1,036,471 sh (-3.88%)
Joel Greenblatt 3,119 sh (-4.09%)
Vanguard Health Care Fund 19,001,100 sh (-4.81%)
Bill Frels 21,204 sh (-5.23%)
James Barrow 5,876,768 sh (-5.26%)
Alan Fournier 1,198,352 sh (-23.93%)
Ray Dalio 168,069 sh (-25.56%)
David Dreman 4,800 sh (-38.88%)
Lee Ainslie 1,279,314 sh (-48.57%)
Diamond Hill Capital 4,984 sh (-94.39%)
» More
Q4 2013

UNH Guru Trades in Q4 2013

Paul Tudor Jones 4,500 sh (New)
Ken Fisher 2,960 sh (New)
John Hussman 100,000 sh (New)
Steven Cohen 77,908 sh (+319.42%)
Dodge & Cox 11,322,985 sh (+82.61%)
NWQ Managers 4,205 sh (+33.32%)
Sarah Ketterer 1,233,818 sh (+31.02%)
Jeremy Grantham 7,664,565 sh (+15.96%)
Leon Cooperman 1,352,033 sh (+10.38%)
Jeff Auxier 139,495 sh (+6.97%)
Tom Gayner 606,900 sh (+5.31%)
Vanguard Health Care Fund 19,992,000 sh (+5.21%)
Chris Davis 15,589,667 sh (+4.77%)
HOTCHKIS & WILEY 5,932,574 sh (+3.39%)
Joel Greenblatt 3,201 sh (+2.63%)
Diamond Hill Capital 4,986 sh (+0.04%)
David Dreman 4,800 sh (unchged)
Bernard Horn 41,284 sh (unchged)
Bill Nygren 3,460,000 sh (unchged)
Bill Frels 21,204 sh (unchged)
Ray Dalio Sold Out
Lee Ainslie Sold Out
Alan Fournier Sold Out
Mario Gabelli 378,838 sh (-1.14%)
James Barrow 5,744,256 sh (-2.25%)
RS Investment Management 742,030 sh (-28.41%)
Pioneer Investments 106,872 sh (-53.53%)
» More
Q1 2014

UNH Guru Trades in Q1 2014

Larry Robbins 1,692,631 sh (New)
Ray Dalio 67,900 sh (New)
Jim Simons 103,748 sh (New)
George Soros 196,400 sh (New)
Robert Olstein 46,000 sh (New)
Joel Greenblatt 16,083 sh (+402.44%)
David Dreman 7,768 sh (+61.83%)
Pioneer Investments 140,954 sh (+31.89%)
Dodge & Cox 13,078,536 sh (+15.5%)
Diamond Hill Capital 5,609 sh (+12.49%)
Sarah Ketterer 1,385,240 sh (+12.27%)
HOTCHKIS & WILEY 6,607,426 sh (+11.38%)
NWQ Managers 4,525 sh (+7.61%)
Bernard Horn 42,384 sh (+2.66%)
Bill Frels 21,454 sh (+1.18%)
Leon Cooperman 1,362,333 sh (+0.76%)
Bill Nygren 3,460,000 sh (unchged)
John Hussman Sold Out
Paul Tudor Jones Sold Out
Jeff Auxier 139,445 sh (-0.04%)
Vanguard Health Care Fund 19,766,300 sh (-1.13%)
Tom Gayner 598,000 sh (-1.47%)
Ken Fisher 2,857 sh (-3.48%)
Jeremy Grantham 7,348,107 sh (-4.13%)
Chris Davis 14,450,329 sh (-7.31%)
Mario Gabelli 345,200 sh (-8.88%)
James Barrow 5,206,990 sh (-9.35%)
RS Investment Management 453,530 sh (-38.88%)
Steven Cohen 8,451 sh (-89.15%)
» More
Q2 2014

UNH Guru Trades in Q2 2014

John Hussman 100,000 sh (New)
John Burbank 2,928 sh (New)
Paul Tudor Jones 3,900 sh (New)
NWQ Managers 22,565 sh (+398.67%)
Joel Greenblatt 45,563 sh (+183.3%)
Dodge & Cox 16,538,560 sh (+26.46%)
Ray Dalio 82,200 sh (+21.06%)
Ken Fisher 3,279 sh (+14.77%)
Robert Olstein 51,000 sh (+10.87%)
Mario Gabelli 371,500 sh (+7.62%)
Tom Gayner 627,000 sh (+4.85%)
HOTCHKIS & WILEY 6,900,939 sh (+4.44%)
Sarah Ketterer 1,444,440 sh (+4.27%)
Vanguard Health Care Fund 20,115,900 sh (+1.77%)
Bill Nygren 3,520,000 sh (+1.73%)
Diamond Hill Capital 5,612 sh (+0.05%)
Steven Cohen 52,200 sh (unchged)
Bernard Horn 42,384 sh (unchged)
Jim Simons Sold Out
Larry Robbins Sold Out
George Soros Sold Out
RS Investment Management 452,030 sh (-0.33%)
Bill Frels 21,266 sh (-0.88%)
Jeff Auxier 137,995 sh (-1.04%)
David Dreman 7,685 sh (-1.07%)
Chris Davis 13,522,334 sh (-6.42%)
James Barrow 4,738,801 sh (-8.99%)
Jeremy Grantham 6,420,403 sh (-12.63%)
Leon Cooperman 652,699 sh (-52.09%)
Pioneer Investments 25,470 sh (-81.93%)
» More
» Details

Insider Trades

Latest Guru Trades with UNH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Leon Cooperman 2014-06-30 Reduce -52.09%0.78%$74.95 - $82.34 $ 86.2510%652699
John Hussman 2014-06-30 New Buy0.63%$74.95 - $82.34 $ 86.2510%100000
Dodge & Cox 2014-06-30 Add 26.46%0.27%$74.95 - $82.34 $ 86.2510%16538560
George Soros 2014-06-30 Sold Out 0.16%$74.95 - $82.34 $ 86.2510%0
Joel Greenblatt 2014-06-30 Add 183.3%0.03%$74.95 - $82.34 $ 86.2510%45563
Ray Dalio 2014-06-30 Add 21.06%0.01%$74.95 - $82.34 $ 86.2510%82200
John Burbank 2014-06-30 New Buy$74.95 - $82.34 $ 86.2510%2928
John Hussman 2014-03-31 Sold Out 0.54%$69.74 - $81.62 $ 86.2515%0
George Soros 2014-03-31 New Buy0.16%$69.74 - $81.62 $ 86.2515%196400
Dodge & Cox 2014-03-31 Add 15.5%0.15%$69.74 - $81.62 $ 86.2515%13078536
Ray Dalio 2014-03-31 New Buy0.05%$69.74 - $81.62 $ 86.2515%67900
Joel Greenblatt 2014-03-31 Add 402.44%0.02%$69.74 - $81.62 $ 86.2515%16083
David Dreman 2014-03-31 Add 61.83%0.02%$69.74 - $81.62 $ 86.2515%7768
Lee Ainslie 2013-12-31 Sold Out 1.2%$66.94 - $75.19 $ 86.2520%0
John Hussman 2013-12-31 New Buy0.54%$66.94 - $75.19 $ 86.2520%100000
Dodge & Cox 2013-12-31 Add 82.61%0.4%$66.94 - $75.19 $ 86.2520%11322985
Vanguard Health Care Fund 2013-12-31 Add 5.21%0.23%$66.94 - $75.19 $ 86.2520%19992000
Leon Cooperman 2013-12-31 Add 10.38%0.13%$66.94 - $75.19 $ 86.2520%1352033
Ray Dalio 2013-12-31 Sold Out 0.1%$66.94 - $75.19 $ 86.2520%0
Lee Ainslie 2013-09-30 Reduce -48.57%1.07%$65.27 - $75.18 $ 86.2520%1279314
Dodge & Cox 2013-09-30 Add 474.26%0.41%$65.27 - $75.18 $ 86.2520%6200700
Vanguard Health Care Fund 2013-09-30 Reduce -4.81%0.23%$65.27 - $75.18 $ 86.2520%19001100
Ray Dalio 2013-09-30 Reduce -25.56%0.03%$65.27 - $75.18 $ 86.2520%168069
David Dreman 2013-09-30 Reduce -38.88%0.01%$65.27 - $75.18 $ 86.2520%4800
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 15.80
UNH's P/E(ttm) is ranked higher than
84% of the 37 Companies
in the Global Health Care Plans industry.

( Industry Median: 19.30 vs. UNH: 15.80 )
UNH' s 10-Year P/E(ttm) Range
Min: 6.3   Max: 28.39
Current: 15.8

6.3
28.39
P/B 2.57
UNH's P/B is ranked higher than
65% of the 37 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.05 vs. UNH: 2.57 )
UNH' s 10-Year P/B Range
Min: 1.02   Max: 6.95
Current: 2.57

1.02
6.95
P/S 0.69
UNH's P/S is ranked higher than
62% of the 37 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.52 vs. UNH: 0.69 )
UNH' s 10-Year P/S Range
Min: 0.26   Max: 1.83
Current: 0.69

0.26
1.83
PFCF 15.91
UNH's PFCF is ranked higher than
73% of the 37 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.74 vs. UNH: 15.91 )
UNH' s 10-Year PFCF Range
Min: 5.04   Max: 28.05
Current: 15.91

5.04
28.05
EV-to-EBIT 9.59
UNH's EV-to-EBIT is ranked higher than
86% of the 37 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.17 vs. UNH: 9.59 )
UNH' s 10-Year EV-to-EBIT Range
Min: 4.4   Max: 17
Current: 9.59

4.4
17
PEG 1.10
UNH's PEG is ranked higher than
92% of the 37 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.89 vs. UNH: 1.10 )
UNH' s 10-Year PEG Range
Min: 0.26   Max: 1.42
Current: 1.1

0.26
1.42
Shiller P/E 18.39
UNH's Shiller P/E is ranked higher than
86% of the 37 Companies
in the Global Health Care Plans industry.

( Industry Median: 34.33 vs. UNH: 18.39 )
UNH' s 10-Year Shiller P/E Range
Min: 6.81   Max: 47.26
Current: 18.39

6.81
47.26
Current Ratio 0.74
UNH's Current Ratio is ranked higher than
61% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.91 vs. UNH: 0.74 )
UNH' s 10-Year Current Ratio Range
Min: 0.62   Max: 2.87
Current: 0.74

0.62
2.87
Quick Ratio 0.74
UNH's Quick Ratio is ranked higher than
61% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.91 vs. UNH: 0.74 )
UNH' s 10-Year Quick Ratio Range
Min: 0.62   Max: 2.87
Current: 0.74

0.62
2.87

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.52
UNH's Dividend Yield is ranked higher than
61% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.42 vs. UNH: 1.52 )
UNH' s 10-Year Dividend Yield Range
Min: 0.03   Max: 1.59
Current: 1.52

0.03
1.59
Dividend Payout 0.22
UNH's Dividend Payout is ranked higher than
89% of the 37 Companies
in the Global Health Care Plans industry.

( Industry Median: 9999.00 vs. UNH: 0.22 )
UNH' s 10-Year Dividend Payout Range
Min: 0.03   Max: 0.26
Current: 0.22

0.03
0.26
Dividend growth (3y) 37.50
UNH's Dividend growth (3y) is ranked higher than
75% of the 8 Companies
in the Global Health Care Plans industry.

( Industry Median: 37.50 vs. UNH: 37.50 )
UNH' s 10-Year Dividend growth (3y) Range
Min: 0   Max: 198.8
Current: 37.5

0
198.8
Yield on cost (5-Year) 74.02
UNH's Yield on cost (5-Year) is ranked higher than
86% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.04 vs. UNH: 74.02 )
UNH' s 10-Year Yield on cost (5-Year) Range
Min: 1.48   Max: 78.46
Current: 74.02

1.48
78.46
Share Buyback Rate 3.30
UNH's Share Buyback Rate is ranked higher than
82% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: -0.30 vs. UNH: 3.30 )
UNH' s 10-Year Share Buyback Rate Range
Min: 6   Max: -4.3
Current: 3.3

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 0.80
UNH's Price/DCF (Projected) is ranked higher than
81% of the 37 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.01 vs. UNH: 0.80 )
UNH' s 10-Year Price/DCF (Projected) Range
Min: 0.34   Max: 1.85
Current: 0.8

0.34
1.85
Price/Median PS Value 1.13
UNH's Price/Median PS Value is ranked higher than
73% of the 37 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.13 vs. UNH: 1.13 )
UNH' s 10-Year Price/Median PS Value Range
Min: 0.51   Max: 4.33
Current: 1.13

0.51
4.33
Price/Peter Lynch Fair Value 1.19
UNH's Price/Peter Lynch Fair Value is ranked higher than
89% of the 37 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.50 vs. UNH: 1.19 )
UNH' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.36   Max: 1.36
Current: 1.19

0.36
1.36
Earnings Yield (Greenblatt) 10.40
UNH's Earnings Yield (Greenblatt) is ranked higher than
85% of the 34 Companies
in the Global Health Care Plans industry.

( Industry Median: 8.80 vs. UNH: 10.40 )
UNH' s 10-Year Earnings Yield (Greenblatt) Range
Min: 5.9   Max: 22.6
Current: 10.4

5.9
22.6
Forward Rate of Return (Yacktman) 18.33
UNH's Forward Rate of Return (Yacktman) is ranked higher than
87% of the 32 Companies
in the Global Health Care Plans industry.

( Industry Median: 14.60 vs. UNH: 18.33 )
UNH' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 15.1   Max: 49.2
Current: 18.33

15.1
49.2

Business Description

Industry: Health Care Plans » Health Care Plans
Compare:ESRX, WLP, HUM, AET, CI » details
Traded in other countries:UNH.Germany
UnitedHealth Group Incorporated is a Minnesota corporation incorporated in January 1977. It is a health and well-being company helps people live healthier lives and help make health care work better. The Company is helping individual's access quality care at an affordable cost; simplifying health care administration and delivery; strengthening the physician/patient relationship; promoting evidence-based care; and empowering physicians, health care professionals, consumers, employers and other participants in the health system with actionable data to make better, more informed decisions. UnitedHealthcare serves the health benefits needs of individuals across life's stages through three businesses. UnitedHealthcare Employer & Individual serves individual consumers and employers. The unique health needs of seniors are served by UnitedHealthcare Medicare & Retirement. UnitedHealthcare Community & State serves the public health marketplace, offering states innovative Medicaid solutions. The Company's revenues are derived from premiums on risk-based products; fees from management, administrative, technology and consulting services; sales of a wide variety of products and services related to the broad health and well-being industry; and investment and other income. The Company's two business platforms have four reportable segments: UnitedHealthcare, which includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State; OptumHealth; OptumInsight; and OptumRx. The Company's competitors include managed health care companies, insurance companies, HMOs, TPAs and business services outsourcing companies, health care professionals. For its UnitedHealthcare businesses, competitors include Aetna Inc., Cigna Corporation, Coventry Health Care, Inc., Health Net, Inc., Humana Inc., Kaiser Permanente, WellPoint, Inc., For its OptumRx businesses, competitors include Medco Health Solutions, Inc., CVS Caremark Corporation and Express Scripts, Inc. The Company is subject to various levels of federal regulation.
» More Articles for UNH

Headlines

Articles On GuruFocus.com
Despite Regulation, Transparency and Competition, Aetna Looks Competitive in the Industry Aug 29 2014 
Let The Winners Run Aug 13 2014 
UnitedHealth Group Up on Weak Day for the Dow Jul 17 2014 
Jobs Data Helps U.S. Equity Markets Reach New Highs Jul 05 2014 
Chris Davis Comments on UnitedHealth Group Jun 24 2014 
Health Insurance Companies in Your Portfolio Jun 24 2014 
Mario Gabelli Comments on UnitedHealth Group Inc. Jun 09 2014 
4 Stocks Growing Their Cash Dividends Jun 09 2014 
Oakmark’s Bill Nygren's Top Holdings Led by Bank of America and Oracle May 29 2014 
Guru Sarah Ketterer's Top Five Positions as of the First Quarter May 14 2014 


More From Other Websites
Insurers Fight Hospital Mergers As ACA Snubs Fee For Service Medicine Sep 14 2014
Stocks close down ahead of Fed meeting; energy hit Sep 12 2014
Retrophin, Gilead, And Our Healthcare Values Sep 12 2014
UNITEDHEALTH GROUP INC Files SEC form 8-K, Regulation FD Disclosure Sep 12 2014
Georgia and New York Health Departments Receive America's Health Rankings Champion Award from ASTHO... Sep 11 2014
The Market's Thorns, Roses, and All Time Highs... Sep 09 2014
ObamaCare, Government Giveaways, Inefficiencies and Abuse Top $850 Billion Sep 09 2014
Dow Component UnitedHealth Group (UNH) To Go Ex-dividend Tomorrow Sep 09 2014
Four New Partner Organizations Join Optum Labs Research Collaborative Sep 09 2014
Third Annual National Medicare Education Week Offers Help Before Open Enrollment Period Sep 08 2014
UNITEDHEALTH GROUP INC Files SEC form 8-K, Regulation FD Disclosure Sep 05 2014
UnitedHealth (UNH) Hits 52-Week High on Expansion Plans Sep 05 2014
Hackers break into server for Obamacare website - U.S. officials Sep 04 2014
Hackers break into server for Obamacare website: U.S. officials Sep 04 2014
Hackers break into server for Obamacare website -U.S. officials Sep 04 2014
Today's Market Thorns, Roses, and All Time Highs Sep 04 2014
US stocks end lower; caution before jobs report Sep 04 2014
Injured Veterans to Cycle 355 Miles from Waltham, Mass., to New York City for 2014 UnitedHealthcare... Sep 04 2014
The Market's Roses, Thorns, and All Time Highs... Sep 03 2014
Five Ways ACA And Employers Shift Costs This Open Enrollment Season Sep 01 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK